4 Diagnostic challenges in acromegaly: a case-based review

References 

1. Alexander L , Appleton D , Hall R , et al.   Epidemiology of acromegaly in the Newcastle region . Clinical Endocrinology (Oxford) . 1980;12:71–79
2. Bengtsson BA , Edén S , Ernest I , et al.   Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984 . Acta Medica Scandinavica . 1988;223:327–335
   • MEDLINE
   • CrossRef
3. Ritchie CM , Atkinson AB , Kennedy AL , et al.   Ascertainment and natural history of treated acromegaly in Northern Ireland . Ulster Medical Journal . 1990;59:5562
4. Etxabe J , Gaztambide S , Latorre P , et al.   Acromegaly: an epidemiological study . Journal of Endocrinological Investigation . 1993;16:181–187
   • MEDLINE
5. Holdaway IM , Rajasoorya C . Epidemiology of acromegaly . Pituitary . 1999;2:29–41
   • MEDLINE
   • CrossRef
6. Daly AF , Petrossians P , Beckers A . An overview of the epidemiology and genetics of acromegaly . Journal of Endocrinological Investigation . 2005;28(Suppl.):67–69
   • MEDLINE
7. Nabarro JD . Acromegaly . Clinical Endocrinology (Oxford) . 1987;26:481–512
8. Nachtigall L , Delgado A , Swearingen B , et al.   Changing patterns in diagnosis and therapy of acromegaly over two decades . Journal of Clinical Endocrinology and Metabolism . 2008;93:2035–2041
9. Chanson P , Salenave S . Acromegaly . Orphanet Journal of Rare Diseases . 2008;3:17
   • CrossRef
10. Chanson P , Timsit J , Masquet C , et al.   Cardiovascular effects of the somatostatin analog octreotide in acromegaly . Annals of Internal Medicine . 1990;133:197–201
    • MEDLINE
11. Lioté F , Orcel P . Osteoarticular disorders of endocrine origin . Baillière's Best Practice & Research Clinical Rheumatology . 2000;14:251–276
12. Melmed S , Colao A , Barkan A , et al.   Guidelines for acromegaly management: an update . Journal of Clinical Endocrinology and Metabolism . 2009;94:1509–1517
13. Colao A , Ferone D , Marzullo P , et al.   Systemic complications of acromegaly: epidemiology, pathogenesis, and management . Endocrine Reviews . 2004;25:102–152
    • MEDLINE
    • CrossRef
14. Vitale G , Pivonello R , Lombardi G , et al.   Cardiovascular complications in acromegaly . Minerva Endocrinologica . 2004;29:77–88
    • MEDLINE
15. Clemmons DR , Van Wyk JJ , Ridgway EC , et al.   Evaluation of acromegaly by radioimmunoassay of somatomedin-C . The New England Journal of Medicine . 1979;301:1138–1142
    • MEDLINE
    • CrossRef
16. Dimaraki EV , Jaffe CA , DeMott-Friberg R , et al.   Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up . Journal of Clinical Endocrinology and Metabolism . 2002;87:3537–3542
17. Daughaday WH , Starkey RH , Saltman S , et al.   Characterization of serum growth hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of serum GH . Journal of Clinical Endocrinology and Metabolism . 1987;65:617–623
18. Rieu M , Girard F , Bricaire H , et al.   The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly . Journal of Clinical Endocrinology and Metabolism . 1982;55:147–153
19. Sakharova AA , Dimaraki EV , Chandler WF , et al.   Clinically silent somatotropinomas may be biochemically active . Journal of Clinical Endocrinology and Metabolism . 2005;90:2117–2121
20. Yamada S , Sano T , Stefaneanu L , et al.   Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary . Journal of Clinical Endocrinology and Metabolism . 1993;76:352–356
21. Kovacs K , Lloyd R , Horvath E , et al.   Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization . American Journal of Pathology . 1989;134:345–353
22. Horvath E , Kovacs K , Killinger DW . Silent corticotropic adenomas of the pituitary gland: a histologic, immunocytologic and ultrastructural study . American Journal of Pathology . 1980;98:617–638
23. Giustina A , Barkan A , Casanueva FF , et al.   Criteria for cure of acromegaly: a consensus statement . Journal of Clinical Endocrinology and Metabolism . 2000;85:526–529
24. Trainer PJ . Acromegaly – consensus, what consensus? . Journal of Clinical Endocrinology and Metabolism . 2002;87:3534–3536
25. Melmed S , Casanueva F , Cavagnini F , et al.   Consensus statement: medical management of acromegaly . European Journal of Endocrinology . 2005;153:737–740
26. Freda PU , Reyes CM , Nuruzzaman AT , et al.   Basal and glucose-suppressed GH levels less than 1 microg/L in newly diagnosed acromegaly . Pituitary . 2003;6:175–180
    • MEDLINE
    • CrossRef
27. Freda PU , Post KD , Powell JS , et al.   Evaluation of disease status with sensitive measures of growth hormone secretion in 60 post-operative patients with acromegaly . Journal of Clinical Endocrinology and Metabolism . 1998;83:3808–3816
28. Trainer PJ , Barth J , Sturgeon C , et al.   Consensus statement on the standardisation of GH assays . European Journal of Endocrinology . 2006;155:1–2
29. Pokrajac A , Wark G , Ellis AR , et al.   Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice . Clinical Endocrinology (Oxford) . 2007;67:65–70
30. Arafat AM , Möhlig M , Weickert MO , et al.   Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index . Journal of Clinical Endocrinology and Metabolism . 2008;93:1254–1262
31. Clemmons DR . IGF-I assays: current assay methodologies and their limitations . Pituitary . 2007;10:121–128
    • MEDLINE
    • CrossRef
32. Milani D , Carmichael JD , Welkowitz J , et al.   Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development . Journal of Clinical Endocrinology and Metabolism . 2004;89:2271–2274